ALSPW Spineway SAS

2023 Financial Calendar

2023 Financial Calendar

Press release        February 1st, 2023– 6 pm



Spineway 2023 Financial Calendar

SPINEWAY (ISIN : FR0011398874 – ALSPW), a specialist in innovative implants for the treatment of severe spine pathologies, announced today its 2023 financial calendar* :

February 10, 2023:2022 annual results
April 4, 2023:Combined General Meeting
April 13, 2023:Publication of Q1 2023 turnover
July 11, 2023:Publication of half-year 2023 turnover
September 19, 2023:First half-year results
October 12, 2023:Publication of Q3 2013 turnover

* This calendar is indicative. Spineway reserves its rights to modify the above dates if it seems it necessary. Results will be released after the market closes (Euronext, Paris).

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.

Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.

Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015).

ISIN: FR001400BVK2 - ALSPW        





SPINEWAY



Shareholder-services line



Available Tuesday through Thursday



+33 (0)806 706 060



Eligible PEA / PME





ALSPW





Euronext Growth











AELIUM



Finance & Communication



Investor relations



Solène Kennis





Contacts:

Attachment



EN
01/02/2023

Underlying

ALSPWSpineway SAS

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Spineway SAS

 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

SPINEWAY : Evolution Surgical distribuera les prothèses discales CP-ES...

SPINEWAY : Evolution Surgical distribuera les prothèses discales CP-ESP et LP-ESP en Australie  Ecully, le 22 octobre 2025 – 8h30 SPINEWAY Evolution Surgical distribuera les prothèses discales CP-ESP et LP-ESP de Spineway en Australie  Spineway, spécialiste des implants innovants pour le traitement des pathologies sévères de la colonne vertébrale (rachis), annonce la conclusion d'un accord avec Evolution Surgical, pour la distribution exclusive de ses prothèses discales ESP en Australie à partir du 25 octobre 2025. Orthotech, l’ancien distributeur sur cette zone, assurera en collaboratio...

10m 1 EN
 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

Spineway : Revenue growth in the third quarter

Spineway : Revenue growth in the third quarter Ecully, October 14, 2025 – 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575   +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M revenue8,6189,110      -5% Unaudited consolidated data The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, benefited, in line with its expectations, from a deferral of orders from major accounts to the third quarter of 2025 and generated revenue of €3.0 million over the period, up from €2.6 millio...

October 14, 2025 1 EN
 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

SPINEWAY : Croissance du chiffre d’affaires au 3ème trimestre

SPINEWAY : Croissance du chiffre d’affaires au 3ème trimestre Ecully, le 14 octobre 2025 – 18h30 SPINEWAYCroissance du chiffre d’affaires au 3ème trimestre En milliers d’euros20252024Variationen %CA 3ème trimestre3 0452 575   + 18%CA 2ème trimestre2 7453 465- 21%CA 1er trimestre2 8283 070      - 8%CA 9 mois8 6189 110       - 5% Données consolidées non auditées Spineway, spécialiste des implants innovants pour le traitement des pathologies sévères de la colonne vertébrale (rachis), a bénéficié, conformément à ses anticipations, d’un report des commandes de grands comptes sur le 3ème trimes...

October 14, 2025 1 EN
 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

Spineway : H1 2025 results - Continued improvement in results and fina...

Spineway : H1 2025 results - Continued improvement in results and financial position Press release         Ecully, July 30, 2025 – 7 p.m.   SPINEWAY H1 2025 results  Continued improvement in results and financial positionFull-year 2025 growth target confirmed In thousands of eurosConsolidated financial statements – UnauditedH1 2025H1 2024Revenue5,5736,535Cost of sales(1,702)(2,059)Gross margin% of revenue3,87069%4,47668%Net operating expensesOf which general operating costs(5,068)(2,086)(5,246)(2,232)Of which personnel expenses(2,374)(2,685)Operating income/(loss)(1,197)(770)Fina...

July 30, 2025 1 EN
 PRESS RELEASE
Free
ALSPW SPINEWAY SAS

SPINEWAY : Résultats semestriels 2025 - Poursuite de l’amélioration de...

SPINEWAY : Résultats semestriels 2025 - Poursuite de l’amélioration des résultats et de la situation financière Communiqué de presse        Ecully, le 30 juillet 2025 –19h SPINEWAY Résultats semestriels 2025 Poursuite de l’amélioration des résultats et de la situation financièreObjectif de croissance confirmé pour l’année 2025 En milliers d'eurosComptes consolidés – Non auditésS1 2025S1 2024Chiffre d'affaires5 5736 535Coût des ventes- 1 702- 2 059Marge brute% du CA3 87069%4 47668%Coûts nets d’exploitationDont coûts de fonctionnement- 5 068- 2 086- 5 246- 2 232Dont charges de personnel-...

July 30, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch